热点栏目自选股 数据中心 行情中心资金流向模拟交易客户端美银证券发布研报称，维持 石药集团 “跑输大市”评级，目标价由4.1港元降至4港元，基于主要产品减价影响。该行调整对石药2024年至2026年收入预测，介乎下调1%至上调3%。同时上调去年及今年纯利预测19%及1%，但下调明年纯利预测12%美银证券发布研报称，维持石药集团（01093）“跑输大市”评级，目标价由4.1港元降至4港元，基于主要...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.